Multiple Assemblies exist for SMTL entry 3mo2
human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E67; X-RAY DIFFRACTION 2.49 Å

	SMTL ID 3mo2.1 Ligands ZINC ION; 7-[(5-aminopentyl)oxy]-N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 Oligo-state monomer
	SMTL ID 3mo2.2 Ligands ZINC ION; 7-[(5-aminopentyl)oxy]-N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 Oligo-state monomer
	SMTL ID 3mo2.3 Ligands ZINC ION; S-ADENOSYL-L-HOMOCYSTEINE; 7-[(5-aminopentyl)oxy]-N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 Oligo-state monomer
	SMTL ID 3mo2.4 Ligands ZINC ION; S-ADENOSYL-L-HOMOCYSTEINE; 7-[(5-aminopentyl)oxy]-N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 Oligo-state monomer
	SMTL ID 3mo2.5 Ligands ZINC ION; 7-[(5-aminopentyl)oxy]-N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 Oligo-state homo-dimer
	SMTL ID 3mo2.6 Ligands ZINC ION; S-ADENOSYL-L-HOMOCYSTEINE; 7-[(5-aminopentyl)oxy]-N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 Oligo-state homo-dimer